Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma

Zhi-Qiang Hu,Hao-Yang Xin,Chu-Bin Luo,Jia Li,Zheng-Jun Zhou,Ji-Xue Zou,Shao-Lai Zhou

DOI: https://doi.org/10.1007/s00262-020-02685-7

2020-08-06

Abstract:Recent studies suggested that the immune microenvironment and mutational landscape are associated with the response to immune-based therapy in several types of cancer. The roles of those factors in Chinese HCC remain largely unknown. In this study, we obtained 182 FFPE samples of HCC cohort that were previously subjected to NGS (49 WGS, 18 WES, and 115 targeted sequencing). We performed immunohistochemistry to detect CD3, CD4, CD8, CD57, Foxp3, CD68, CD66b, and PD-L1 expression in the samples. We identified diverse associations between the mutational landscape and the immune microenvironment in the HCC samples. High mutational burden and an aristolochic acid-dominated mutational signature were both correlated with elevated tumoral PD-L1 expression and CD3+ T-cell infiltration and high numbers of CD68+ TAMs and CD66b+ TANs. CD4+ and CD8+ T cells exhibited lower infiltration levels in tumors with mutations in <i>AXIN1</i>/<i>CTNNB1</i> and in tumors with aflatoxin-dominant mutational signatures. Moreover, tumors with <i>TP53</i> mutations had less CD8+ T-cell infiltration and more Foxp3+ Treg-cell infiltration than those without <i>TP53</i> mutations. Kaplan–Meier survival analysis revealed that the presence of CD8+, Foxp3+, CD66b+, or CD68+ immune cells; tumoral PD-L1 expression alone; or the presence of CD8+ or Foxp3+ cells combined with <i>TP53</i> mutation were predictive of recurrence and poor overall survival after curative resection. In conclusion, the association between the mutational landscape and the immune microenvironment warrants further analysis to determine its impact on patient outcomes to guide personalized immune-based therapy for Chinese patients with HCC.

oncology,immunology

What problem does this paper attempt to address?

The paper aims to explore the association between the mutation landscape and the immune microenvironment in Chinese hepatocellular carcinoma (HCC) patients and analyze the impact of these factors on patient prognosis. Specifically, the main objectives of the study include:

1. **Relationship between mutation burden and immune cell infiltration**: The study examined the relationship between mutation burden and immune cell infiltration in 49 HCC samples that underwent whole-genome sequencing (WGS). The results showed that tumors with a high mutation burden (>10) had more CD3+ T cells, CD66b+ tumor-associated neutrophils (TANs), and CD68+ tumor-associated macrophages (TAMs), indicating that a high mutation burden is associated with an inflammatory microenvironment.

2. **Relationship between mutation characteristics and immune cell infiltration**: Four main mutation characteristics (aristolochic acid exposure, aflatoxin exposure, aging, and alcohol intake) were identified using the non-negative matrix factorization (NMF) algorithm. The study found that the mutation characteristic dominated by aristolochic acid was associated with more CD3+ T cell infiltration, while the mutation characteristic dominated by aflatoxin led to less CD8+ T cell infiltration, suggesting that aflatoxin may inhibit immune response.

3. **Relationship between driver gene mutations and the immune microenvironment**: The relationship between the top 12 driver gene mutations and the immune microenvironment was analyzed in 182 HCC samples that underwent next-generation sequencing (NGS). The results indicated that TP53 mutations were associated with lower CD8+ T cell infiltration and higher Foxp3+ regulatory T cell (Treg cell) infiltration, suggesting that TP53 mutations may lead to an immunosuppressive microenvironment. Additionally, AXIN1/CTNNB1 mutations were associated with lower CD3+, CD4+, and CD8+ T cell infiltration, indicating that these mutations may lead to "cold" tumors, thereby conferring resistance to immune checkpoint inhibitors.

4. **Prognostic value of immune cell infiltration**: The study showed that higher CD8+ T cell infiltration was associated with better overall survival (OS) and lower recurrence rates, while higher Foxp3+ Treg cell infiltration was associated with poorer prognosis. Moreover, higher CD66b+ TANs and CD68+ TAMs infiltration were also associated with poorer prognosis.

5. **Combination of driver gene mutations and immune cell infiltration to predict HCC prognosis**: The study found that the combination of TP53 mutations and CD8+ T cell or Foxp3+ Treg cell infiltration could better predict the prognosis of HCC patients. Patients without TP53 mutations and with high CD8+ T cell density had better prognosis, while patients with TP53 mutations and high Foxp3+ Treg cell infiltration had poorer prognosis.

In summary, this paper reveals the impact of the relationship between the mutation landscape and the immune microenvironment on the prognosis of Chinese HCC patients through detailed analysis, providing important evidence for further guiding personalized immunotherapy.